HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiahuan Chen Selected Research

Therapeutics

1/2021Evaluation of Extended-Interval Dabigatran Dosing in Older Patients With Non-Valvular Atrial Fibrillation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiahuan Chen Research Topics

Disease

2Atrial Fibrillation
01/2022 - 01/2021
1Atherosclerosis
10/2021
1Hemorrhage
01/2021
1Cardiovascular Diseases (Cardiovascular Disease)
10/2015
1Coronary Artery Disease (Coronary Atherosclerosis)
10/2015

Drug/Important Bio-Agent (IBA)

1Biomarkers (Surrogate Marker)IBA
01/2022
1activin AIBA
10/2021
1CreatinineIBA
01/2021
1DabigatranFDA Link
01/2021
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
10/2015
111-dehydro-thromboxane B2IBA
10/2015

Therapy/Procedure

1Therapeutics
01/2021
1Aftercare (After-Treatment)
01/2021
1Secondary Prevention
10/2015